Indeksnr.

Kemisk navn

EF nr.

CAS nr.

Klassificering

Mærkning

Specifikke koncentrationsgrænser, M-faktorer og ATE-værdier

Noter

Fareklasse- og kategorikode(r)

Faresætningskode(r)

Piktogram-, signalordskode(r)

Faresætningskode(r)

Suppl. faresætningskode(r)

»014-052-00-7

silanamin, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolyseprodukter med silica; pyrogen, syntetisk amorf, nanoformer af og overfladebehandlet siliciumdioxid

272-697-1

68909-20-6

STOT RE 2

H373 (lunger) (indånding)

GHS08

Wng

H373 (lunger) (indånding)

EUH066«

»035-005-00-7

ammoniumbromid

235-183-8

12124-97-9

Repr. 1B

Lact.

STOT SE 3

STOT RE 1

Eye Irrit. 2

H360FD

H362

H336

H372 (nervesystem)

H319

GHS08

GHS07

Dgr

H360FD

H362

H336

H372 (nervesystem)

H319«

»050-032-00-4

dibutyltinbis(2-ethylhexanoat)

220-481-2

2781-10-4

Muta. 2

Repr. 1B

STOT RE 1

H341

H360FD

H372 (immunsystem)

GHS08

Dgr

H341

H360FD

H372 (immunsystem)«

»050-033-00-X

dibutyltindi(acetat)

213-928-8

1067-33-0

Muta 2

Repr. 1B

STOT RE 1

H341

H360FD

H372 (immunsystem)

GHS08

Dgr

H341

H360FD

H372 (immunsystem)«

»052-001-00-0

tellur

236-813-4

13494-80-9

Repr. 1B

Lact.

H360Df

H362

GHS08

Dgr

H360Df

H362«

»052-002-00-6

tellurdioxid

231-193-1

7446-07-3

Repr. 1B

Lact.

H360Df

H362

GHS08

Dgr

H360Df

H362«

»056-005-00-3

bariumdibortetraoxid

237-222-4

13701-59-2

Repr. 1B

Acute Tox. 4

Acute Tox. 3

H360FD

H332

H301

GHS08

GHS06

Dgr

H360FD

H332

H301

indånding:

ATE = 1,5 mg/l (støv eller tåger)

oral:

ATE = 100 mg/kg kropsvægt«

»601-097-00-8

propylbenzen

203-132-9

103-65-1

Flam. Liq. 3

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2

H226

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H304

H335

H411«

»603-243-00-6

2,2-dimethylpropan-1-ol, tribromderivat; 3-brom-2,2-bis(brommethyl)propan-1-ol

253-057-0

36483-57-5; 1522-92-5

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341«

»604-096-00-0

piperonylbutoxid (ISO); 2-(2-butoxyethoxy)ethyl-6-propylpiperonylether

200-076-7

51-03-6

STOT SE 3

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H335

H319

H400

H410

GHS07

GHS09

Wng

H335

H319

H410

EUH066

M = 1

M = 1«

»604-097-00-6

2,4,6-tri-tert-butylphenol

211-989-5

732-26-3

Repr. 1B

Acute Tox. 4

STOT RE 2

Skin Sens. 1B

H360D

H302

H373 (lever)

H317

GHS08

GHS07

Dgr

H360D

H302

H373 (lever)

H317

oral:

ATE = 500 mg/kg kropsvægt«

»604-098-00-1

4,4′-sulfonyldiphenol; bisphenol S

201-250-5

80-09-1

Repr. 1B

H360FD

GHS08

Dgr

H360FD«

»606-153-00-5

benzophenon

204-337-6

119-61-9

Carc. 1B

H350

GHS08

Dgr

H350«

»606-154-00-0

quinoclamin (ISO); 2-amino-3-chlor-1,4-naphthoquinon

220-529-2

2797-51-5

Carc. 2

Repr. 2

Acute Tox. 4

STOT RE 2

Eye Irrit. 2

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H351

H361d

H302

H373 (blodsystem, nyrer)

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H302

H373 (blodsystem, nyrer)

H319

H317

H410

oral:

ATE = 500 mg/kg kropsvægt

M = 10

M = 10«

»607-756-00-6

exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-ylacrylat; isobornylacrylat;

227-561-6

5888-33-5

Skin Sens. 1A

H317

GHS07

Wng

H317«

»607-757-00-1

daminozid (ISO); 4-(2,2-dimethylhydrazin)-4-oxobutansyre; N-dimethylaminosuccinamidsyre

216-485-9

1596-84-5

Carc. 2

H351

GHS08

Wng

H351«

»607-758-00-7

4,4′-oxydi(benzensulfonhydrazid)

201-286-1

80-51-3

Self-react. D

Aquatic Acute 1

Aquatic Chronic 1

H242

H400

H410

GHS02

GHS09

Dgr

H242

H410

M = 1

M = 1«

»607-759-00-2

toluen-4-sulfonhydrazid

216-407-3

1576-35-8

Self-react. D

H242

GHS02

Dgr

H242«

»607-760-00-8

2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethylacetat; C.I. Disperse Blue 124

239-203-6

15141-18-1

Skin Sens. 1A

H317

GHS07

Wng

H317

Skin Sens. 1A; H317: C ≥ 0,001 %«

»607-761-00-3

perfluorheptansyre; tridecafluorheptansyre

206-798-9

375-85-9

Repr. 1B

STOT RE 1

H360D

H372 (lever)

GHS08

Dgr

H360D

H372 (lever)«

»607-762-00-9

methyl-N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorphenyl)-β-alaninat valifenalat

—

283159-90-0

Carc. 2

Aquatic Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411«

»607-763-00-4

6-[C12-18-alkyl-(forgrenet, umættet)-2,5-dioxopyrrolidin-1-yl]hexansyre, natrium- og tris(2-hydroxyethyl)ammoniumsalte

—

—

Repr. 1B

Eye Irrit. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319«

»607-764-00-X

6-[(C10-C13)-alkyl-(forgrenet, umættet)-2,5-dioxopyrrolidin-1-yl]hexansyre

—

2156592-54-8

Repr. 1B

Eye Irrit. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319«

»607-765-00-5

6-[C12-18-alkyl-(forgrenet, umættet)-2,5-dioxopyrrolidin-1-yl]hexansyre

—

—

Repr. 1B

H360FD

GHS08

Dgr

H360FD«

»613-341-00-0

clofentezin (ISO); 3,6-bis(o-chlorphenyl)-1,2,4,5-tetrazin

277-728-2

74115-24-5

Aquatic Chronic 1

H410

GHS09

Wng

H410

M = 1«

»613-342-00-6

theophyllin; 1,3-dimethyl-3,7-dihydro-1H-purin-2,6-dion

200-385-7

58-55-9

Repr. 1B

H360D

GHS08

Dgr

H360D«

»613-343-00-1

pyridalyl (ISO); 2,6-dichlor-4-(3,3-dichlorallyloxy)phenyl 3-[5-(trifluormethyl)-2-pyridyloxy]propylether

—

179101-81-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1 000

M = 100«

»613-344-00-7

pyridin-2-thiol-1-oxid, natriumsalt; pyrithionnatrium; natriumpyrithion

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Acute Tox. 3

Acute Tox. 3

Acute Tox. 4

STOT RE 1

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 2

H331

H311

H302

H372 (nervesystem)

H315

H319

H317

H400

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H302

H372 (nervesystem)

H315

H319

H317

H410

EUH070

indånding:

ATE = 0,5 mg/l (støv eller tåger)

dermal:

ATE = 790 mg/kg kropsvægt

oral:

ATE = 500 mg/kg kropsvægt

M = 100«

»613-345-00-2

1,3,5-triazin-2,4,6-triamin;

melamin

203-615-4

108-78-1

Carc. 2

STOT RE 2

H351

H373 (urinveje)

GHS08

Wng

H351

H373 (urinveje)«

»615-046-00-2

1,3-bis(1-isocyanato-1-methylethyl)benzen; [m-TMXDI]

220-474-4

2778-42-9

Resp. Sens. 1

Skin Sens. 1A

H334

H317

GHS08

Dgr

H334

H317«

»615-047-00-8

1,3-bis(isocyanatomethyl)benzen; [m-XDI]

222-852-4

3634-83-1

Resp. Sens. 1

Skin Sens. 1A

H334

H317

GHS08

Dgr

H334

H317

Skin Sens. 1A; H317: C ≥ 0,001 %«

»615-048-00-3

2,4,6-triisopropyl-m-phenylendiisocyanat

218-485-4

2162-73-4

Resp. Sens. 1

Skin Sens. 1

H334

H317

GHS08

Dgr

H334

H317«

»615-049-00-9

1,5-naphthylendiisocyanat

[indeholdende < 0,1 % (w/w) af partikler med en aerodynamisk diameter på mindre end 50 μm]

221-641-4

3173-72-6

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

Resp. Sens. 1

Skin Sens. 1A

Aquatic Chronic 3

H335

H315

H319

H334

H317

H412

GHS07

GHS08

Dgr

H335

H315

H319

H334

H317

H412«

»615-050-00-4

1,5-naphthylendiisocyanat

[indeholdende ≥ 0,1 % (w/w) af partikler med en aerodynamisk diameter på mindre end 50 μm]

221-641-4

3173-72-6

Acute Tox. 2

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

Resp. Sens. 1

Skin Sens. 1A

Aquatic Chronic 3

H330

H335

H315

H319

H334

H317

H412

GHS06

GHS08

Dgr

H330

H335

H315

H319

H334

H317

H412

indånding:

ATE = 0,27 mg/l (støv eller tåger)«

»616-237-00-3

fluopicolid (ISO); 2,6-dichlor-N-[3-chlor-5-(trifluormethyl)-2-pyridylmethyl]benzamid

—

239110-15-7

Repr. 2

H361d

GHS08

Wng

H361d«

»616-238-00-9

N-(2-nitrophenyl)phosphortriamid

477-690-9

874819-71-3

Repr. 1B

STOT RE 2

H360Fd

H373 (nyrer)

GHS08

Dgr

H360Fd

H373 (nyrer)«

»616-239-00-4

N-(5-chlor-2-isopropylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid isoflucypram

—

1255734-28-1

Repr. 2

Acute Tox. 4

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H361f

H332

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f

H332

H317

H410

indånding:

ATE = 2,2 mg/l (støv eller tåger)

M = 10

M = 1«

»616-240-00-X

reaktionsblanding af 3-(difluormethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methannaphthalen-5-yl]pyrazol-4-carboxamid og 3-(difluormethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methannaphthalen-5-yl]pyrazol-4-carboxamid [relativt indhold af syn-isomerer ≥ 78 % og anti-isomerer ≤ 15 %] isopyrazam

—

881685-58-1

Carc. 2

Repr. 1B

Skin Sens. 1B

Aquatic Acute 1 Aquatic Chronic 1

H351

H360D

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H317

H410

Repr. 1B; H360D:

C ≥ 3 %

M = 10

M = 10«

»650-058-00-1

margosa, ekstrakt [fra kerner af Azadirachta indica, der er ekstraheret med vand og yderligere behandlet med organiske opløsningsmidler]

283-644-7

84696-25-3

Repr. 2

Skin Sens. 1

Aquatic Chronic 1

H361d

H317

H410

GHS08

GHS07

GHS09

Wng

H361d

H317

H410

M = 10«

Indeksnr.

Kemisk navn

EF nr.

CAS nr.

Klassificering

Mærkning

Specifikke koncentrationsgrænser, M-faktorer og ATE-værdier

Noter

Fareklasse- og kategorikode(r)

Faresætningskode(r)

Piktogram-, signalordskode(r)

Faresætningskode(r)

Suppl. faresætningskode(r)

»014-001-00-9

trichlorsilan

233-042-5

10025-78-2

Flam. Liq. 1

Water-react. 1

Acute Tox. 3

Acute Tox. 4

Skin Corr. 1A

Eye Dam. 1

H224

H260

H331

H302

H314

H318

GHS02

GHS06

GHS05

Dgr

H224

H260

H331

H302

H314

EUH014

EUH029

EUH071

indånding:

ATE = 7,6 mg/l (dampe)

oral:

ATE = 1 000 mg/kg kropsvægt«

»023-001-00-8

divanadiumpentaoxid; vanadiumpentaoxid

215-239-8

1314-62-1

Muta. 2

Carc. 1B

Repr. 2

Lact.

Acute Tox. 3

Acute Tox. 2

STOT SE 3

STOT RE 1

Aquatic Chronic 2

H341

H350

H361fd

H362

H301

H330

H335

H372 (luftveje, indånding)

H411

GHS06

GHS08

GHS09

Dgr

H341

H350

H361fd

H362

H301

H330

H335

H372 (luftveje, indånding)

H411

indånding:

ATE = 0,05 mg/l (støv eller tåger)

oral:

ATE = 220 mg/kg kropsvægt«

»601-024-00-X

cumen

202-704-5

98-82-8

Flam. Liq. 3

Carc. 1B

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2

H226

H350

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H304

H335

H411«

»603-014-00-0

2-butoxyethanol; ethylenglycolmonobutylether

203-905-0

111-76-2

Acute Tox. 3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

H331

H302

H315

H319

GHS06

Dgr

H331

H302

H315

H319

indånding:

ATE = 3 mg/l (dampe)

oral:

ATE = 1 200 mg/kg kropsvægt«

»603-107-00-6

2-(2-methoxyethoxy)ethanol; diethylenglycolmonomethylether

203-906-6

111-77-3

Repr. 1B

H360D

GHS08

Dgr

H360D

Repr. 1B; H360D: C ≥ 3 %«

»604-030-00-0

4,4′-isopropylidendiphenol; bisphenol A

201-245-8

80-05-7

Repr. 1B

STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360F

H335

H318

H317

H400

H410

GHS08

GHS07

GHS05

GHS09

Dgr

H360F

H335

H318

H317

H410

M = 1

M = 10«

»607-111-00-9

2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propandiyldiacrylat; 2,2-bis(acryloyloxymethyl)butylacrylat;

trimethylolpropantriacrylat

239-701-3

15625-89-5

Carc. 2

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H315

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H315

H319

H317

H410

M = 1

M = 1

D«

»607-230-00-6

2-ethylhexansyre og salte heraf, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Repr. 1B

H360D

GHS08

Dgr

H360D«

»607-253-00-1

cyfluthrin (ISO); α-cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat

269-855-7

68359-37-5

Lact.

Acute Tox. 2

Acute Tox. 2

STOT SE 1

Aquatic Acute 1

Aquatic Chronic 1

H362

H330

H300

H370 (nervesystem)

H400

H410

GHS06

GHS08

GHS09

Dgr

H362

H330

H300

H370 (nervesystem)

H410

indånding:

ATE = 0,14 mg/l (støv eller tåger)

oral:

ATE = 14 mg/kg kropsvægt

M = 1 000 000

M = 1 000 000 «

»607-254-00-7

beta-cyfluthrin (ISO); reaktionsblanding af rel-(R)-cyan(4-fluor-3-phenoxyphenyl)methyl (1S,3S)-3-(2,2-dichlorethenyl)-2,2-dimethylcyclopropan-1-carboxylat og rel-(R)-cyan(4-fluor-3-phenoxyphenyl)methyl (1S,3R)-3-(2,2-dichlorethenyl)-2,2-dimethylcyclopropan-1-carboxylat

—

1820573-27-0

Lact.

Acute Tox. 2

Acute Tox. 2

STOT SE 1

Aquatic Acute 1

Aquatic Chronic 1

H362

H330

H300

H370 (nervesystem)

H400

H410

GHS06

GHS08

GHS09

Dgr

H362

H330

H300

H370 (nervesystem)

H410

indånding:

ATE = 0,081 mg/l (støv eller tåger)

oral:

ATE = 11 mg/kg kropsvægt

M = 1 000 000

M = 1 000 000 «

»607-734-00-6

pentakalium 2,2′,2″2‴,2″″-(ethan-1,2-diylnitrilo)pentaacetat

404-290-3

7216-95-7

Repr. 1B

Acute Tox. 4

STOT RE 2

Eye Irrit. 2

H360D

H332

H373 (indånding)

H319

GHS08

GHS07

Dgr

H360D

H332

H373 (indånding)

H319

Repr. 1B; H360D: C ≥ 3 %

indånding:

ATE = 1,5 mg/l (støv eller tåger)«

»607-735-00-1

N-carboxymethyliminobis(ethylennitrilo)tetra(eddikesyre)

200-652-8

67-43-6

Repr. 1B

Acute Tox. 4

STOT RE 2

Eye Irrit. 2

H360D

H332

H373 (indånding)

H319

GHS08

GHS07

Dgr

H360D

H332

H373 (indånding)

H319

Repr. 1B; H360D: C ≥ 3 %

indånding:

ATE = 1,5 mg/l (støv eller tåger)«

»607-736-00-7

pentanatrium (carboxylatmethyl)iminobis(ethylennitrilo)tetraacetat

205-391-3

140-01-2

Repr. 1B

Acute Tox. 4

STOT RE 2

H360D

H332

H373 (indånding)

GHS08

GHS07

Dgr

H360D

H332

H373 (indånding)

Repr. 1B; H360D: C ≥ 3 %

indånding:

ATE = 1,5 mg/l (støv eller tåger)«

»608-032-00-2

acetamiprid (ISO); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N'-cyan-N-methylethanimidamid E)-N1-[(6-chlor-3-pyridyl)methyl]-N2-cyan-N1-methylacetamidin

—

135410-20-7 160430-64-8

Repr. 2

Acute Tox. 3

Aquatic Chronic 1

Aquatic Acute 1

H361d

H301

H410

H400

GHS08

GHS06

GHS09

Dgr

H361d

H301

H410

oral:

ATE = 140 mg/kg kropsvægt

M = 10

M = 10«

»609-042-00-X

pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xyliden

254-938-2

40487-42-1

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GSH09

Wng

H361d

H410

M = 100

M = 10«

»613-012-00-1

bentazon (ISO); 3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid

246-585-8

25057-89-0

Repr. 2

Acute Tox. 4

Eye Irrit. 2

Skin Sens. 1

H361d

H302

H319

H317

GHS08

GHS07

Wng

H361d

H302

H319

H317

oral: ATE = 1 600 mg/kg kropsvægt«

»616-164-00-7

dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamid (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid

149961-52-4

Carc. 2

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H351

H361d

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H332

H410

indånding:

ATE = 1,3 mg/l (støv eller tåger)

M = 100

M = 100«